Iregene Therapeutics Co., Ltd.
Clinical trials sponsored by Iregene Therapeutics Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Brain cell injection trial hopes to ease Parkinson's symptoms Results expected Sep 2027 (estimated)
-
Brain cell injection trial hopes to ease Parkinson's symptoms
Disease control Recruiting nowThis early-phase trial tests a new treatment called NouvNeu001 for people with advanced Parkinson's disease. It involves injecting special brain cells directly into areas of the brain that control movement. The study will enroll just 5 participants to see if the procedure is safe…
Phase 1/2 • Sponsor: iRegene Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Brain cell transplant trial offers hope for rare Parkinson's-Like disease
Disease control Recruiting nowThis early-stage trial tests a single injection of dopamine-producing cells directly into the brain for people with multiple system atrophy (MSA), a rare and severe movement disorder. The main goal is to check safety and side effects in 9 participants aged 30 to 70. Researchers w…
Phase 1 • Sponsor: iRegene Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC